Development and clinical translation of P2X7 receptor antagonists: A potential therapeutic target in coronary artery disease?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development and clinical translation of P2X7 receptor antagonists: A potential therapeutic target in coronary artery disease?

Published:2022-09 Issue: Volume:237 Page:108228
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Genetzakis Elijah,Gilchrist Jayson,Kassiou Michael,Figtree Gemma A.

Funder

National Health and Medical Research Council

Office of Health and Medical Research

NSW Health

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference248 articles.

1. Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction;Abbate;Circulation.,2008

2. Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease;Abbate;Circulation Research,2020

3. Discovery and structure–activity relationships of a series of pyroglutamic acid amide antagonists of the P2X7 receptor;Abdi;Bioorganic & Medicinal Chemistry Letters,2010

4. The P2X7 receptor: A main player in inflammation;Adinolfi;Biochemical Pharmacology,2018

5. Cutting edge: a natural P451L mutation in the cytoplasmic domain impairs the function of the mouse P2X7 receptor;Adriouch;The Journal of Immunology.,2002

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. THE effect of P2X7 receptor activation on functional responses of human left internal mammary artery;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-09-03

2. Unlocking the therapeutic potential of P2X7 receptor: a comprehensive review of its role in neurodegenerative disorders;Frontiers in Pharmacology;2024-07-30

3. Functional role of P2X7 purinergic receptor in cancer and cancer-related pain;Purinergic Signalling;2024-05-21

4. A patent review of P2X7 receptor antagonists to treat inflammatory diseases (2018–present);Expert Opinion on Therapeutic Patents;2024-04-02

5. The double roles of T cell-mediated immune response in the progression of MASLD;Biomedicine & Pharmacotherapy;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3